Palvella Therapeutics Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Palvella Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $228.4. The average 1-year stock price forecast is 56.28% higher than the current stock price, while the lowest is $205 (+40.27%) and the highest is $267 (+82.69%).

Price Target: $228.4 (+56.28%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$205	$228.4	$232	$267
Change	+40.27%	+56.28%	+58.74%	+82.69%

Analyst Ratings

The average analyst rating for Palvella Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	16	15	15	15	15	16
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	15	15	15	15	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Graig Suvannavejh Mizuho Securities	Mizuho Securities	Buy Maintains $240 → $232	Buy	Maintains	$240 → $232	+58.74%	Oct 29, 2026
Joshua Schimmer Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $210	Buy	Maintains	$210	+43.69%	Oct 22, 2026
Kaveri Pohlman Clear Street	Clear Street	Buy Maintains $220	Buy	Maintains	$220	+50.53%	Oct 20, 2026
Andrew Fein H.C. Wainwright	H.C. Wainwright	Buy Reiterates $246	Buy	Reiterates	$246	+68.32%	Oct 20, 2026
Ryan Deschner Raymond James	Raymond James	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Oct 16, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

24.63M

EPS This Year

-6.39

from -3.71

EPS Next Year

-7.91

from -6.39

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-
Operating Income	-18.04M	-11.87M	-14.10M	-38.60M	-93.28M
Net Income	-27.55M	18.69M	-17.43M	-41.72M	-94.52M
EPS	-	-	-	-3.71	-6.39
Free Cash Flow	-	-	-	-36.02M	-78.81M
No. Analysts	-	-	-	-	15

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

Chart

EPS	2026	2027	2028
High	-3.95
Avg	-6.39
Low	-7.84

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-